Formula One team McLaren have inked a multi-year partnership with innovative healthcare firm Sanofi.
The deal will see McLaren work with Sanofi’s Industrial Affairs team to achieve greatness in manufacturing operations, which will allow Sanofi to meet the patients’ needs from all over the world through an effective use of their global network and also support the supply of their broad portfolio. McLaren will be using their digital and analytical prowess to help Sanofi focus on major factors impacting performances and help anticipate and resolve them as well.
Also Read – Formula One 2022 Team Sponsors: McLaren
Aside from the technical leadership of Formula One, the partnership will also be focused on bringing a racing mindset, a fast pace environment to accelerate improvements, emulate the competitiveness, and foster a ‘one Sanofi spirit’. The partnership is not only aimed at improvement and growth in motorsport but also in the healthcare industry as well.
Commenting on the partnership, Zak Brown, CEO, McLaren Racing, said:
“We are delighted to be partnering with Sanofi. It is an important opportunity for two global brands who share values to work together to maximise performance through our bespoke Accelerator programme. We look forward to continuing to collaborate with Sanofi to make a positive impact not only in manufacturing but to help Sanofi improve patients’ lives.”
Paul Hudson, CEO, Sanofi, added:
“We are thrilled to partner with McLaren and learn from their winning spirit and culture of going over and above. I see a lot of commonalities in our shared values to stretch, with courage and determination, so we can maximise performance and operational excellence. We want to run our lines with the speed, precision and efficiency of an F1 racing team.”
After a tough start to the season, McLaren scored their first podium of the season courtesy Lando Norris’ third-place finish in Imola. The team will be hoping to carry that momentum forward into the inaugural Miami Grand Prix on May 8.
Leave a Reply